Does SECUKINUMAB Cause Skin plaque? 2,073 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,073 reports of Skin plaque have been filed in association with SECUKINUMAB (COSENTYX). This represents 1.4% of all adverse event reports for SECUKINUMAB.
2,073
Reports of Skin plaque with SECUKINUMAB
1.4%
of all SECUKINUMAB reports
23
Deaths
183
Hospitalizations
How Dangerous Is Skin plaque From SECUKINUMAB?
Of the 2,073 reports, 23 (1.1%) resulted in death, 183 (8.8%) required hospitalization, and 21 (1.0%) were considered life-threatening.
Is Skin plaque Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 2,073 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Skin plaque?
ETANERCEPT (778)
OMALIZUMAB (607)
ADALIMUMAB (597)
METHOTREXATE (535)
RISANKIZUMAB-RZAA (278)
CYCLOSPORINE (276)
CLOBETASOL (227)
DUPILUMAB (200)
TRIAMCINOLONE (156)
INFLIXIMAB (146)
Which SECUKINUMAB Alternatives Have Lower Skin plaque Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG